Engineering protein thermal stability: sequence statistics point to residue substitutions in α-helices L Menéndez-Arias, P Argosf Journal of molecular biology 206 (2), 397-406, 1989 | 336 | 1989 |
Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments L Menéndez-Arias Antiviral research 98 (1), 93-120, 2013 | 249 | 2013 |
Targeting HIV: antiretroviral therapy and development of drug resistance L Menendez-Arias Trends in pharmacological sciences 23 (8), 381-388, 2002 | 243 | 2002 |
Molecular basis of human immunodeficiency virus drug resistance: an update L Menéndez-Arias Antiviral research 85 (1), 210-231, 2010 | 225 | 2010 |
Primary structure of the major allergen of yellow mustard (Sinapis alba L.) seed, Sin a I L MENÉNDEZ‐ARIAS, I Moneo, J Domínguez, R Rodríguez European Journal of Biochemistry 177 (1), 159-166, 1988 | 205 | 1988 |
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis A Airaksinen, N Pariente, L Menéndez-Arias, E Domingo Virology 311 (2), 339-349, 2003 | 194 | 2003 |
Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase L Menéndez-Arias Virus research 134 (1-2), 124-146, 2008 | 192 | 2008 |
Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance L Menéndez-Arias, M Álvarez, B Pacheco Current opinion in virology 8, 1-9, 2014 | 191 | 2014 |
RNA virus fitness E Domingo, L Menéndez‐Arias, JJ Holland Reviews in medical virology 7 (2), 87-96, 1997 | 184 | 1997 |
Update and latest advances in antiretroviral therapy L Menéndez-Arias, R Delgado Trends in pharmacological sciences 43 (1), 16-29, 2022 | 182 | 2022 |
Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells E Pauls, A Ruiz, R Badia, M Permanyer, A Gubern, E Riveira-Muñoz, ... The Journal of Immunology 193 (4), 1988-1997, 2014 | 169 | 2014 |
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection L Menéndez-Arias, M Álvarez Antiviral research 102, 70-86, 2014 | 152 | 2014 |
Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses Y Ma, E Frutos-Beltrán, D Kang, C Pannecouque, E De Clercq, ... Chemical Society Reviews 50 (7), 4514-4540, 2021 | 147 | 2021 |
Characterization of a new oriental-mustard (Brassica juncea) allergen, Braj IE: detection of an allergenic epitope RI Monsalve, MA Gonzalez De La Pena, L Menendez-Arias, C Lopez-Otin, ... Biochemical Journal 293 (3), 625-632, 1993 | 141 | 1993 |
Mutation rates and intrinsic fidelity of retroviral reverse transcriptases L Menéndez-Arias Viruses 1 (3), 1137-1165, 2009 | 139 | 2009 |
Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases L Menéndez-Arias Academic Press 71, 91-147, 2002 | 139 | 2002 |
Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants EJ Lien, A Das, P Nandy, S Ren, H Kleinkauf, H von Döhren, ... Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des …, 1997 | 136 | 1997 |
Viral reverse transcriptases L Menéndez-Arias, A Sebastián-Martín, M Álvarez Virus research 234, 153-176, 2017 | 128 | 2017 |
Role of a dipeptide insertion between codons 69 and 70 of HIV‐1 reverse transcriptase in the mechanism of AZT resistance A Mas, M Parera, C Briones, V Soriano, MA Martínez, E Domingo, ... The EMBO Journal, 2000 | 127 | 2000 |
HIV protease cleaves poly (A)-binding protein E Álvarez, A Castelló, L Menéndez-Arias, L Carrasco Biochemical Journal 396 (2), 219-226, 2006 | 126 | 2006 |